Cited by 6Pluripotent Stem Cells ResearchCRISPR and Genetic EngineeringNeurogenesis and neuroplasticity mechanisms

The DOI matches its Crossref record; the references it cites are not checked yet.

Human iPSC Models in Drug Discovery: Opportunities and Challenges

Silva, M.C., Cross, A., Brandon, N.J., Haggarty, S.J.·2017·Comprehensive Medicinal Chemistry III

Overview

Integrity signals

Registry

Crossref · 10.1016/b978-0-12-409547-2.12284-x

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Human stem cell-derived neurons allow access to physiologically relevant cell types and protein complexes, offering the advantage of modeling pathogenic tau species without the need for overexpression of heterologous genes, in the context of the patient genomic background.

    “Human stem cell-derived neurons allow access to physiologically relevant cell types and protein complexes, offering the advantage of modeling pathogenic tau species without the need for overexpression of heterologous genes, in the context of the patient genomic background”

Citations

The citation lists haven’t been fetched yet

References 257 · Cited by 6

Research works printed but not linked: 2

  1. Mattis, 2015, Modeling Huntingtons Disease With Patient-Derived Neurons, Brain Res.
  2. Martinez, R.; Hsu, S.; Ezerskiy, L. A.; Shu, H. J.; Mennerick, S.; Goate, A. M.; Karch, C. M. Efficient Production, Banking and Terminal Differentiation of Neural Progenitor Cells From Human Induced Pluripotent Stem Cells. (in press).

Metadata

Authors
Silva, M. C., Cross, A., Brandon, N. J., & Haggarty, S. J.
Affiliations
  • Harvard University (US)
  • AstraZeneca (United States) (US)
Venue
Comprehensive Medicinal Chemistry III
Publisher
Elsevier
Published
2017
Pages
48-73
OpenAlex
W2551793832
Cited by
6
References
257
Citations by year
2024: 1 · 2022: 1 · 2020: 1 · 2019: 2 · 2017: 1
FWCI
1.23
Type
book chapter
Language
en
Open access
closed
Locations
Elsevier eBooks (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
  • Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
Keywords
human induced pluripotent stem cells, iPSC-derived disease models, drug discovery, high-throughput phenotypic screening, CRISPR/Cas9 genome editing, biomarker discovery, central nervous system disorders, organoids, drug toxicity testing, precision medicine, patient stratification, drug response signatures

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review